(Q30781186)

26 June 2017

1 reference

title

Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review (English)

1 reference

26 June 2017

1 reference

Hans-Joachim Ulmer

1

1 reference

PubMed ID

12662376

26 June 2017

Andree Beckerling

series ordinal

2

1 reference

PubMed ID

12662376

26 June 2017

Gudrun Gatz

series ordinal

3

1 reference

26 June 2017

1 April 2003

1 reference

26 June 2017

1 reference

26 June 2017

8

1 reference

26 June 2017

95-104

1 reference

26 June 2017

2

1 reference

Helicobacter pylori: epidemiology and routes of transmission

26 June 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Regular review: treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00129.X

10.1046/J.1523-5378.2003.00129.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

12662376